Predictions
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
21.01.23
21.01.23
-
24.05.24
24.05.24
-
26.01.23
26.01.23
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Hutchison China MediTech Ltd ADR
Start price
Target price
Perf. (%)
€15.50
19.01.23
19.01.23
-
19.01.24
19.01.24
-21.29%
20.01.24
20.01.24
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.78
13.01.23
13.01.23
€17.00
31.05.24
31.05.24
-9.18%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€15.65
03.01.23
03.01.23
€22.00
31.12.25
31.12.25
23.98%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€45.00
03.01.23
03.01.23
€70.00
31.12.25
31.12.25
-10.09%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Sartorius AG ST
Start price
Target price
Perf. (%)
€315.50
02.01.23
02.01.23
€444.00
02.01.24
02.01.24
5.23%
07.01.23
07.01.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Novocure Ltd
Start price
Target price
Perf. (%)
€68.89
02.01.23
02.01.23
€30.00
31.12.25
31.12.25
71.43%
05.01.23
05.01.23
Could be very worthwhile Investment >20% year
Opko Health Inc.
Start price
Target price
Perf. (%)
€1.14
27.12.22
27.12.22
-
27.12.23
27.12.23
11.81%
24.04.23
24.04.23
Risky Investment
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€47.20
07.12.22
07.12.22
-
07.12.23
07.12.23
-16.53%
10.12.22
10.12.22
Risky Investment
Canopy Growth Corp
Start price
Target price
Perf. (%)
€3.58
21.11.22
21.11.22
-
21.11.23
21.11.23
-85.09%
22.11.23
22.11.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Canopy Growth Corp
Start price
Target price
Perf. (%)
€3.63
19.11.22
19.11.22
€2.50
19.11.23
19.11.23
-46.91%
11.03.23
11.03.23
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Syneos Health, Inc.
Start price
Target price
Perf. (%)
€26.12
04.11.22
04.11.22
-
04.11.23
04.11.23
23.91%
10.11.22
10.11.22
Risky Investment
Orpea Nom.
Start price
Target price
Perf. (%)
€7.95
28.10.22
28.10.22
-
28.10.23
28.10.23
-16.20%
29.10.22
29.10.22
Could be very worthwhile Investment >20% year
Orpea Nom.
Start price
Target price
Perf. (%)
€9.52
26.10.22
26.10.22
-
26.10.23
26.10.23
-30.01%
30.10.22
30.10.22
Could be very worthwhile Investment >20% year
Medpace Holdings Inc
Start price
Target price
Perf. (%)
€218.90
25.10.22
25.10.22
€190.00
25.10.23
25.10.23
11.47%
26.10.23
26.10.23
Could be worthwhile Investment >10% per year
Viatris Inc.
Start price
Target price
Perf. (%)
€9.76
18.10.22
18.10.22
-
18.11.26
18.11.26
13.97%
11.03.24
11.03.24
Probably not worthwhile Investment
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.44
17.10.22
17.10.22
-
17.10.23
17.10.23
-7.41%
22.12.22
22.12.22
Risky Investment
Invitae Corp
Start price
Target price
Perf. (%)
€2.14
16.10.22
16.10.22
-
16.10.23
16.10.23
-3.57%
18.02.23
18.02.23
Risky Investment
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.55
13.10.22
13.10.22
€2.30
13.10.23
13.10.23
42.55%
19.11.22
19.11.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Invitae Corp
Start price
Target price
Perf. (%)
€2.47
27.09.22
27.09.22
-
27.09.23
27.09.23
-13.02%
15.10.22
15.10.22
Risky Investment